Scientists test new Weight-Loss Drug's safety with heart and cholesterol meds
NCT ID NCT07362030
Summary
This early-stage study aims to understand how a new investigational drug for obesity, called RAY1225, interacts with four common medications (warfarin, atorvastatin, metformin, and digoxin). It will enroll 32 healthy participants to measure the drug levels in the body and check for safety when these drugs are taken together. The goal is to gather basic information to see if RAY1225 affects how these other medications work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dongguan People's Hospital
Dongguan, China
Conditions
Explore the condition pages connected to this study.